---
title: "I'm designing a Bayesian adaptive trial. Help me: 1) Specify prior distributions for parameters"
description: "AI model comparison: I'm designing a Bayesian adaptive trial. Help me: 1) Specify prior distributions for parameters..."
date: 2025-10-15
category: comparison
layout: Clean
tags:
  - Gemini
  - Mistral
  - AI Comparison
author: SNEOS Community
head:
  - - meta
    - name: description
      content: "AI model comparison: I'm designing a Bayesian adaptive trial. Help me: 1) Specify prior distributions for parameters..."
---

<ChatComparison
  title="I'm designing a Bayesian adaptive trial. Help me: 1) Specify prior distributions for parameters"
  prompt="I'm designing a Bayesian adaptive trial. Help me: 1) Specify prior distributions for parameters"
  :responses='{"Gemini": "Specifying prior distributions is a crucial step in designing a Bayesian adaptive trial. Priors encapsulate existing knowledge (or lack thereof) before the trial begins and are combined with the data to form posterior distributions, which then guide adaptive decisions.\n\nHere\u0027s a structured approach to specifying prior distributions, covering common parameter types and important considerations:\n\n---\n\n## **1. Core Principles for Prior Specification**\n\nBefore diving into specific distributions, keep these principles in mind:\n\n1.  **Reflect Existing Knowledge:** Priors should genuinely reflect what is known or believed about the parameters *before* seeing any trial data. This knowledge can come from:\n    *   **Previous Trials:** Similar studies, meta-analyses.\n    *   **Historical Data:** Real-world evidence, registries.\n    *   **Expert Opinion:** Structured elicitation from clinicians, statisticians, and domain experts.\n    *   **Pilot Studies/Phase 1/2 Data:** Earlier phase results for the same drug/intervention.\n    *   **Theoretical Considerations:** Biological plausibility, known limits.\n\n2.  **Transparency:** Clearly state your chosen priors and provide a robust justification for their selection. This is especially important for regulatory submissions.\n\n3.  **Conjugacy (Practicality):** Whenever possible, choose a prior distribution that is *conjugate* to your likelihood function. This means the posterior distribution will belong to the same family as the prior, simplifying computations significantly \u2013 which is critical in adaptive designs where posteriors are updated frequently.\n\n4.  **Sensitivity Analysis:** Always perform a sensitivity analysis by trying a range of plausible priors (e.g., more skeptical, more enthusiastic, less informative). This helps demonstrate that your conclusions are robust and not overly dependent on a specific prior choice.\n\n---\n\n## **2. Common Parameter Types and Recommended Prior Distributions**\n\nLet\u0027s look at typical parameters encountered in clinical trials and suitable prior distributions.\n\n### **A. For Proportions/Rates (e.g., Response Rate, Success Rate, AE Rate)**\n\n*   **Parameter:** $p \\in [0, 1]$ (e.g., $p_T$ for treatment, $p_C$ for control).\n*   **Likelihood:** Bernoulli or Binomial.\n*   **Conjugate Prior:** **Beta distribution** ($\\text{Beta}(\\alpha, \\beta)$).\n    *   **Interpretation:** $\\alpha$ can be thought of as the number of \u0022prior successes\u0022 and $\\beta$ as the number of \u0022prior failures.\u0022 The mean of a Beta distribution is $\\alpha / (\\alpha \u002B \\beta)$.\n\n*   **How to Choose $\\alpha$ and $\\beta$:**\n\n    1.  **Non-Informative Priors:**\n        *   **Uniform Prior:** $\\text{Beta}(1, 1)$. This assumes all values of $p$ are equally likely. It\u0027s often chosen when there\u0027s truly no prior information, or to demonstrate that results are data-driven.\n        *   **Jeffreys Prior:** $\\text{Beta}(0.5, 0.5)$. This is a common choice for its theoretical properties (e.g., invariance under reparameterization). It places more weight on values near 0 and 1 than the uniform prior.\n        *   **\u0022Slightly Informative\u0022 (Weakly Informative):** $\\text{Beta}(2, 2)$ or $\\text{Beta}(0.5, 0.5)$ for \u0022success\u0022 and \u0022failure\u0022 arms often used in early phases to ensure stable posteriors, or when you have a very vague belief that the rates aren\u0027t extreme.\n\n    2.  **Informative Priors (Most Common in Adaptive Trials):**\n        *   **From Historical Data:** If a previous trial found a response rate of 30% in 100 patients (30 successes, 70 failures), you might use $\\text{Beta}(30, 70)$ or scale it down for less influence (e.g., $\\text{Beta}(3, 7)$ for a \u0022prior effective sample size\u0022 of 10).\n        *   **From Expert Elicitation:**\n            *   Ask experts: \u0022What\u0027s the most likely response rate?\u0022 (gives you the mean, $\\mu = \\alpha/(\\alpha\u002B\\beta)$).\n            *   Ask: \u0022What\u0027s a plausible range (e.g., 95% credible interval)?\u0022 This helps determine the \u0022concentration\u0022 or effective sample size ($\\alpha\u002B\\beta$).\n            *   Example: An expert believes the response rate is around 40% (mean = 0.4) and is fairly certain it\u0027s between 30% and 50%. You can use tools or iterative methods to find $\\alpha, \\beta$ that match this. A common approach: specify a mean and an effective sample size.\n                *   $\\alpha = \\text{mean} \\times \\text{effective sample size}$\n                *   $\\beta = (1 - \\text{mean}) \\times \\text{effective sample size}$\n                *   e.g., mean = 0.4, effective sample size = 20. Then $\\alpha = 0.4 \\times 20 = 8$, $\\beta = 0.6 \\times 20 = 12$. So $\\text{Beta}(8, 12)$.\n\n### **B. For Means (e.g., Change in Biomarker, Pain Score, Continuous Outcome)**\n\n*   **Parameter:** $\\mu \\in (-\\infty, \\infty)$.\n*   **Likelihood:** Normal distribution ($\\text{N}(\\mu, \\sigma^2)$), where $\\sigma^2$ (variance) might be known or unknown.\n*   **Conjugate Prior:**\n    *   **If $\\sigma^2$ is known:** **Normal distribution** ($\\text{N}(\\mu_0, \\tau^2)$).\n        *   $\\mu_0$: Prior mean (your best guess for the true mean).\n        *   $\\tau^2$: Prior variance (reflects your uncertainty about $\\mu_0$). A smaller $\\tau^2$ means more certainty.\n    *   **If $\\sigma^2$ is unknown:** A **Normal-Inverse-Gamma** prior for $(\\mu, \\sigma^2)$ is conjugate. This models $\\mu$ conditionally on $\\sigma^2$ as Normal, and $\\sigma^2$ marginally as Inverse-Gamma.\n        *   Often, you can set a prior on $\\mu$ and a separate prior on $\\sigma^2$ and use MCMC (e.g., in Stan, JAGS, or WinBUGS) if analytical conjugacy is too complex.\n\n*   **How to Choose $\\mu_0$ and $\\tau^2$ (for $\\mu$):**\n\n    1.  **Non-Informative:** A very large $\\tau^2$ (e.g., $10^6$ or $10^8$) effectively makes the prior flat over a wide range. Or use a scale-invariant prior like Jeffreys for mean/variance.\n    2.  **Informative:**\n        *   **From Historical Data/Pilot:** $\\mu_0$ would be the observed mean from a prior study. $\\tau^2$ could be derived from the standard error of that mean, reflecting your belief in how precisely that prior estimate represents the true mean.\n        *   **From Expert Elicitation:**\n            *   Ask: \u0022What\u0027s the most likely value for the mean change?\u0022 (gives $\\mu_0$).\n            *   Ask: \u0022What range would contain the true mean 95% of the time?\u0022 (e.g., from $X$ to $Y$). You can then approximate $\\tau^2$ such that $\\mu_0 \\pm 1.96 \\sqrt{\\tau^2}$ covers this range.\n\n### **C. For Variances/Standard Deviations ($\\sigma^2$ or $\\sigma$)**\n\n*   **Parameter:** $\\sigma^2 \\in (0, \\infty)$ or $\\sigma \\in (0, \\infty)$.\n*   **Likelihood:** Normal.\n*   **Conjugate Prior (for $\\sigma^2$):** **Inverse-Gamma distribution** ($\\text{InvGamma}(\\alpha, \\beta)$).\n    *   This is the conjugate prior for the variance of a Normal distribution (when the mean is unknown). The mean of $\\text{InvGamma}(\\alpha, \\beta)$ is $\\beta/(\\alpha-1)$ for $\\alpha \u003E 1$.\n*   **Alternative (for $\\sigma$):** **Half-Normal, Half-Cauchy, or Lognormal** for the standard deviation ($\\sigma$). These are often easier to interpret and elicit.\n\n*   **How to Choose Parameters:**\n\n    1.  **Non-Informative:**\n        *   For Inverse-Gamma: $\\text{InvGamma}(0.001, 0.001)$ or $\\text{InvGamma}(0.5, 0.5)$ (Jeffreys\u0027 for scale). These are often called \u0022weakly informative\u0022 but can sometimes be too influential for small sample sizes.\n    2.  **Informative:**\n        *   **From Historical Data:** If a prior study had a sample standard deviation $s$, you might center your prior around $s^2$. The precision of this prior (e.g., parameters of the Inverse-Gamma) would depend on your certainty in that historical estimate.\n        *   **From Expert Elicitation:** Ask about the likely range of the standard deviation or variance. It\u0027s often difficult for experts to think directly in terms of variance, so focusing on standard deviation or range is better.\n\n### **D. For Hazard Ratios (HR) in Survival Analysis**\n\n*   **Parameter:** $\\text{HR} \\in (0, \\infty)$. Often, it\u0027s easier to model $\\log(\\text{HR}) \\in (-\\infty, \\infty)$.\n*   **Likelihood:** Cox Proportional Hazards model or parametric survival models.\n*   **Prior (for $\\log(\\text{HR})$):** **Normal distribution** ($\\text{N}(\\mu_{\\text{logHR}}, \\sigma^2_{\\text{logHR}})$).\n*   **Prior (for HR directly):** **Lognormal distribution** (if $\\log(\\text{HR})$ is Normal).\n\n*   **How to Choose Parameters:**\n\n    1.  **Non-Informative:** For $\\log(\\text{HR})$, a $\\text{N}(0, \\text{large variance})$ (e.g., $N(0, 100)$). This implies no prior belief that HR is above or below 1 (i.e., log(HR) is positive or negative).\n    2.  **Informative:**\n        *   **From Historical Data:** If a prior trial showed an HR of 0.7 with a 95% CI of (0.5, 0.98), you can convert these to log scale, find the mean and standard error of $\\log(\\text{HR})$, and use those to parameterize a Normal prior.\n            *   $\\log(0.7) \\approx -0.357$ (prior mean $\\mu_{\\text{logHR}}$).\n            *   Width of CI on log scale: $\\log(0.98) - \\log(0.5) = -0.02 - (-0.69) = 0.67$.\n            *   Standard deviation: $0.67 / (2 \\times 1.96) \\approx 0.17$. So $\\sigma_{\\text{logHR}}^2 \\approx 0.17^2 \\approx 0.029$.\n            *   This would lead to a prior like $\\text{N}(-0.357, 0.029)$.\n        *   **From Expert Elicitation:** Ask experts for their best guess for the HR and a plausible range.\n\n---\n\n## **3. Strategies for Eliciting and Setting Priors**\n\n1.  **Review Existing Literature:** This is the starting point. What\u0027s known about the control arm, the effect size, and the variability?\n2.  **Formal Expert Elicitation:**\n    *   **Sheffey-Tukey Method / Deliberation:** Gather a panel of experts. Present them with hypothetical scenarios or questions about the parameter.\n    *   **\u0022Prior Elicitation\u0022 Software/Tools:** Programs exist that help experts specify a mean and various percentiles (e.g., 5th, 25th, 50th, 75th, 95th) of a parameter, and then fit a distribution (e.g., Beta, Normal, Gamma) to those specified points.\n    *   **Focus on Quantiles:** Experts often find it easier to think about \u0022I\u0027m 90% sure the response rate is between 20% and 40%\u0022 rather than \u0022the variance is 0.005.\u0022\n3.  **Use of \u0022Skeptical\u0022 or \u0022Enthusiastic\u0022 Priors:**\n    *   **Skeptical Prior:** Centered on a null effect (e.g., HR=1, difference=0) or a very small effect, often with high precision. This requires the data to provide very strong evidence to move the posterior away from the null. Useful for regulatory bodies who want to see convincing evidence.\n    *   **Enthusiastic Prior:** Centered on a clinically meaningful effect, often with high precision. Useful for early phase development to quickly identify promising treatments.\n    *   These are often used as part of sensitivity analyses.\n4.  **Borrowing Information:** Priors are the formal mechanism to borrow information from external sources (historical controls, previous trials). For instance, if you have a control arm with ample historical data, you might use a tight, informative prior for its parameters, while using a less informative prior for the novel treatment arm. This is a common feature in platform trials or multi-arm multi-stage (MAMS) designs.\n5.  **Hierarchical Priors:** If you have multiple related parameters (e.g., response rates for several different subgroups, or parameters for multiple arms in a platform trial), you can model them as coming from a common \u0022hyper-prior\u0022 distribution. This allows for \u0022borrowing strength\u0022 across parameters, especially useful when some groups have very little data.\n\n---\n\n## **4. Practical Steps for Your Design**\n\n1.  **List All Parameters:** Identify every parameter in your statistical model for which you need a prior. (e.g., $p_C$, $p_T$, $\\sigma^2$).\n2.  **Determine Likelihood:** For each parameter, determine the likelihood function of the data given that parameter.\n3.  **Select Prior Family:** Choose a conjugate prior distribution family where possible.\n4.  **Parameterize Priors:**\n    *   Start with non-informative priors for initial exploration if unsure.\n    *   Gather all available external data and expert opinion.\n    *   Use elicitation strategies to specify parameters ($\\alpha, \\beta, \\mu_0, \\tau^2$, etc.).\n    *   Document your rationale for each parameter.\n5.  **Visualize Priors:** Plot your prior distributions. Do they look reasonable? Do they cover the plausible range of values?\n6.  **Perform Sensitivity Analysis (Crucial):**\n    *   Run simulations of your adaptive trial using different sets of priors (e.g., your chosen prior, a more skeptical prior, a less informative prior).\n    *   Observe how the choice of prior impacts operating characteristics (e.g., Type I error, power, sample size, stopping probabilities, probability of selecting the best arm).\n    *   If the results change dramatically with minor changes in priors, your design might be too sensitive and require stronger justification for your prior choice or larger sample sizes.\n\nBy following these steps, you can specify robust and defensible prior distributions for your Bayesian adaptive trial, which are fundamental to its proper functioning and interpretation.", "Mistral": "Designing a Bayesian adaptive trial involves specifying prior distributions for the parameters of interest. These priors reflect your initial beliefs about the parameters before any data is collected. Here are some steps and considerations to help you specify prior distributions:\n\n### 1. Identify the Parameters\nFirst, identify the parameters for which you need to specify priors. These could include:\n- Treatment effect (e.g., mean difference, odds ratio)\n- Variance or standard deviation\n- Probability of success (e.g., in a binary outcome trial)\n- Hazard ratio (e.g., in a survival analysis)\n\n### 2. Choose the Type of Prior Distribution\nThe choice of prior distribution depends on the nature of the parameter and the available information. Common choices include:\n- **Normal Distribution**: Often used for parameters like treatment effects.\n- **Beta Distribution**: Commonly used for probabilities (e.g., success rates).\n- **Gamma Distribution**: Used for parameters that are positive and continuous (e.g., variance).\n- **Uniform Distribution**: Used when you have little prior information and want to express a non-informative prior.\n\n### 3. Specify the Parameters of the Prior Distribution\nFor each parameter, you need to specify the parameters of the prior distribution. This could involve:\n- **Mean and Variance**: For a normal distribution.\n- **Shape and Scale**: For a gamma distribution.\n- **Alpha and Beta**: For a beta distribution.\n\n### 4. Incorporate Expert Knowledge and Historical Data\nIf available, use expert knowledge and historical data to inform your priors. This can make your priors more informative and realistic.\n\n### 5. Sensitivity Analysis\nConduct a sensitivity analysis to see how different priors affect your results. This helps ensure that your conclusions are robust to the choice of prior.\n\n### Example: Specifying Priors for a Binary Outcome Trial\nSuppose you are conducting a trial to compare the success rates of a new treatment (p_new) versus a standard treatment (p_std).\n\n#### Parameters:\n- p_new: Probability of success for the new treatment\n- p_std: Probability of success for the standard treatment\n\n#### Prior Distributions:\n- **p_new**: Beta(\u03B1_new, \u03B2_new)\n- **p_std**: Beta(\u03B1_std, \u03B2_std)\n\n#### Specifying the Parameters:\n1. **Historical Data**: If you have historical data suggesting that the standard treatment has a success rate of about 0.5 with a sample size of 100, you might choose:\n   - \u03B1_std = 50 (successes)\n   - \u03B2_std = 50 (failures)\n\n2. **Expert Opinion**: If experts believe the new treatment might have a success rate around 0.6 with a similar level of uncertainty, you might choose:\n   - \u03B1_new = 60 (successes)\n   - \u03B2_new = 40 (failures)\n\n### Example: Specifying Priors for a Continuous Outcome Trial\nSuppose you are comparing the mean treatment effects (\u03BC_new and \u03BC_std) and variances (\u03C3\u00B2_new and \u03C3\u00B2_std) of a new treatment versus a standard treatment.\n\n#### Parameters:\n- \u03BC_new: Mean treatment effect for the new treatment\n- \u03BC_std: Mean treatment effect for the standard treatment\n- \u03C3\u00B2_new: Variance for the new treatment\n- \u03C3\u00B2_std: Variance for the standard treatment\n\n#### Prior Distributions:\n- **\u03BC_new**: Normal(\u03BC_0_new, \u03C3\u00B2_0_new)\n- **\u03BC_std**: Normal(\u03BC_0_std, \u03C3\u00B2_0_std)\n- **\u03C3\u00B2_new**: Inverse-Gamma(\u03B1_new, \u03B2_new)\n- **\u03C3\u00B2_std**: Inverse-Gamma(\u03B1_std, \u03B2_std)\n\n#### Specifying the Parameters:\n1. **Historical Data**: If historical data suggests that the standard treatment has a mean effect of 5 with a variance of 10, you might choose:\n   - \u03BC_0_std = 5\n   - \u03C3\u00B2_0_std = 10\n   - \u03B1_std = 2 (shape parameter)\n   - \u03B2_std = 20 (scale parameter)\n\n2. **Expert Opinion**: If experts believe the new treatment might have a mean effect around 6 with a similar variance, you might choose:\n   - \u03BC_0_new = 6\n   - \u03C3\u00B2_0_new = 10\n   - \u03B1_new = 2 (shape parameter)\n   - \u03B2_new = 20 (scale parameter)\n\n### Conclusion\nSpecifying prior distributions is a critical step in designing a Bayesian adaptive trial. It involves choosing the type of distribution, specifying its parameters, and incorporating expert knowledge and historical data. Conducting a sensitivity analysis can help ensure that your conclusions are robust to the choice of prior."}' published-date="{DateTime.UtcNow:HH:mm}"
/>

## Analysis

This comparison demonstrates the different approaches each AI model takes when responding to the same prompt. Here are the key differences observed:

### Response Characteristics

**Gemini**: Provides a direct response with 220 sentences. 

**Mistral**: Provides a direct response with 42 sentences. 

## Key Takeaways

- Each model brings unique strengths to this type of query
- Response styles vary significantly between models
- Consider your specific use case when choosing between these models

## Try This Comparison Yourself

Want to test these models with your own prompts? Visit [SNEOS.com](https://sneos.com) to compare AI responses side-by-side in real-time.

---

*This comparison was generated using the [SNEOS AI Comparison Tool](https://sneos.com)*
*Published: October 15, 2025 | Models: Gemini, Mistral*
